Elizabeth A Pharo
Dr Elizabeth Pharo is an Early-Mid Career Research Scientist in the ‘Zoonotic and Ex vivo Modelling’ team based at the CSIRO Australian Centre for Disease Preparedness (ACDP) in Geelong, Australia. Elizabeth completed her PhD in the School of Biological Sciences at The University of Melbourne in 2016. She joined CSIRO in 2017 as a Postdoctoral Fellow for the Probing Biosystems Future Science Platform to develop human 3D ex vivo respiratory models to study host pathogen responses to respiratory viruses, particularly emerging zoonotic viruses. In 2020, Elizabeth was appointed as a Research Scientist and has used human lung models to characterize the pathogenesis of different SARS-CoV-2 variants as a broader part of the Coalition for Epidemic Preparedness Innovations (CEPI)-funded vaccine trials at ACDP. More recent work has involved the testing of antivirals against SARS-CoV-2 for external clients and the development of ex vivo airway models for the bat, pig and chicken. Her current work focuses on increasing the complexity of human lung models to better understand mucosal immunity in the lung and the assessment of nebulised therapeutics against Influenza and SARS-CoV-2.
Abstracts this author is presenting: